Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...
ScienceAlert on MSN18h
Parkinson's Discovery Suggests We Could Already Have an FDA-Approved TreatmentParkinson's symptoms mainly result from the death or impairment of dopamine-producing neurons in the brain's substantia nigra ...
Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...
Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
Lancaster University research found that hearing loss may increase the risk of Parkinson’s disease by 57% for every ...
GlobalData on MSN6d
BlueRock accelerates Parkinson’s disease therapy to Phase IIIThe US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback